✦ LIBER ✦

Clinical trial of corynebacterium parvum (intra-lymph-node and intravenous) and radiation therapy in the treatment of head and neck carcinoma

✍ Scribed by Vincent S. T. Cheng; Herman D. Suit; C. C. Wang; John Raker; Sheldon Kaufman; Kenneth Rothman; Alexander Walker; Patricia McNulty

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 480 KB
Volume: 49
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19820115)49:2<239::aid-cncr2820490208>3.0.co;2-#

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The accuracy of head and neck carcinoma

The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck

✍ Taimur Shoaib; David S. Soutar; D. Gordon MacDonald; Ivan G. Camilleri; David J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## BACKGROUND. Sentinel lymph node (SLN) biopsy originally was described as a means of identifying lymph node metastases in malignant melanoma and breast carcinoma. The use of SLN biopsy in patients with oral and oropharyngeal squamous cell carcinoma and clinically N0 necks was investigated to det

Regional lymph node involvement and its

Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma

✍ Charles R. Leemans; Rammohan Tiwari; J. P. Jos Nauta; Isaac Van der Waal; Gordon 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 1 views

Hyperfractionated radiation therapy and

Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (± granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma

✍ André A. Abitbol; Kasi S. Sridhar; Alan A. Lewin; James G. Schwade; William Raub 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

initial entry of 34 patients. Cancer Center, University of Miami School of RESULTS. At a median follow-up of 41 months (range, 12-80 months), 44 patients Medicine, Miami, Florida. were alive with a projected median overall survival of 54 months. Grade 3/4 muco-2 Regional Cancer Center, Baptist Hosp

Immunotherapy with effector cells and IL

Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice

✍ Kazuaki Chikamatsu; Torsten E. Reichert; Yoshiro Kashii; Takao Saito; Shuichi Ka 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 260 KB 👁 1 views

## We have previously reported that immune anti-tumor effector cells, both cytotoxic T lymphocytes (CTLs ) and IL-2-activated natural killer (A-NK) cells, are effective at eliminating human head-and-neck cancer (HNC) targets in vitro and in vivo in xenograft models. In this study, these 2 types of

Staging of head and neck squamous cell c

Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases

✍ Giorgio Cortesina; Tiziana Martone; Emanuela Galeazzi; Martina Olivero; Antonell 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 347 KB 👁 2 views

In head and neck squamous cell carcinomas (HNSCC), metastasis to cervical lymph nodes is a major determinant of patient outcome. To detect metastases, we used the MET oncogene as marker, which encodes the receptor for hepatocyte growth factor/scatter factor, mediating epithelial cell motility and in

Bioreductive alkylating agent porfiromyc

Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck

✍ Bruce G. Haffty; Yung H. Son; Lynn D. Wilson; Rose Papac; Diana Fischer; Sara Ro 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Porfiromycin (methyl mitomycin C) has been shown in laboratory studies to have increased preferential cytotoxicity to hypoxic cells and therefore may provide enhanced therapeutic efficacy over mitomycin C when used in combination with radiation therapy (RT). The purpose of the two clinical studies r